Home > Healthcare > Medical Devices > Therapeutic Devices > kyphoplasty market
Get a free sample of Kyphoplasty Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Kyphoplasty Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Continuous technological advancements in kyphoplasty modalities is one of the significant factors propelling the market demand. The development of innovative and enhanced bone tamp designs, cement delivery systems, and navigation technologies has increased the adoption rate of kyphoplasty devices. Further, the growing integration of advanced imaging technologies such as fluoroscopy, CT scans, bone densitometer, and intraoperative navigation systems to provide improved visualization and guide instrument placement, cement injection, and overall surgical accuracy during surgical procedures among healthcare facilities will contribute to the overall market growth potential. This has led to a growing demand for kyphoplasty devices and is anticipated to continue stimulating the market share.
Stryker, MicroPort Scientific Corporation, Medtronic Inc., DePuy Synthes (Johnson & Johnson Services Inc.), Smith & Nephew, IZI Medical Products, Merit Medical Systems, CareFusion, Joimax GmbH, Joline GmbH & Co. KG, G21 S.r.l., among others.
The bone access devices segment accounted for USD 236.7 million in 2022, backed by the increasing demand for minimally invasive procedures in the field of spine surgery.
The global market for kyphoplasty was valued at USD 635 million in 2022 and is estimated to account for USD 1.1 billion by 2032, owing to growing prevalence of osteoporosis.
The U.S. kyphoplasty market was worth USD 260.7 million in 2022 and is predicted to witness substantial growth through 2032, on account of increasing elderly populace that is more prone to conditions such as osteoporosis and vertebral fractures.